![Francesco Galimi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Francesco Galimi
Direktor/Vorstandsmitglied bei
GENENTA SCIENCE S.P.A.
Vermögen: - $ am 31.05.2026
Profil
Francesco Galimi currently works at Genenta Science SpA, as Director from 2025 and Adicet Therapeutics, Inc., as Chief Medical Officer & Senior Vice President from 2019.
Dr. Galimi also formerly worked at Amgen, Inc., as General Manager-Global Program from 2015 to 2019, Onyx Pharmaceuticals, Inc., as Head-Clinical Development from 2014 to 2015, resTORbio, Inc., as Chief Medical Officer & Senior Vice President, and Adicet Bio, Inc., as Chief Medical Officer & Senior Vice President from 2019 to 2025.
Dr. Galimi received his doctorate degree from the University of Torino School of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
GENENTA SCIENCE SPA -.--% | 30.03.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von Francesco Galimi
| Unternehmen | Position | Beginn |
|---|---|---|
| GENENTA SCIENCE S.P.A. | Direktor/Vorstandsmitglied | 01.01.2025 |
Adicet Therapeutics, Inc.
 Adicet Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2019 |
Ehemalige bekannte Positionen von Francesco Galimi
| Unternehmen | Position | Ende |
|---|---|---|
| ADICET BIO, INC. | Technik-/Wissenschafts-/F&E-Leiter | 13.01.2025 |
| AMGEN INC. | Corporate Officer/Principal | 01.01.2019 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Corporate Officer/Principal | 01.01.2015 |
| ADICET BIO, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
37
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
Adicet Therapeutics, Inc.
Adicet Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Genenta Science SpA
 Genenta Science SpA Pharmaceuticals: MajorHealth Technology Develops gene transfer therapy for the treatment of cancer tumors | Health Technology |
resTORbio, Inc.
 resTORbio, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Adicet Bio, Inc.
 Adicet Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on the development of cell immunotherapies | Health Technology |
